Narrative Review of Studies Regarding Human Papillomavirus (HPV) Infection and HPV Vaccination

Authors

  • Sheetal Bannet
  • Manisha Gupta

Keywords:

Cervical cancer, HPV infection, HPV vaccine, Vaccination challenges, Women Health

Abstract

A woman's cervix, or the opening from the vagina into the uterus, is where cervical cancer begins to grow. The majority of occurrences of cervical cancer (99%) are associated with high-risk human papillomavirus (HPV) infection. HPV is a widespread virus that is spread through sexual contact. While the majority of HPV infections are clear on their own and don't cause any symptoms, chronic diseases can lead to cervical cancer in females. The fourth most frequent malignancy in women is cervical cancer. Around 311,000 women globally lost their lives to cervical cancer in 2018, according to estimates of the disease's 570,000 new cases. In India, HPV vaccination should be introduced into the Universal Immunization Programme (UIP) as a one-time catch-up for teenage females aged 9 to 14 and then regularly starting at 9. The National Technical Advisory Group for Immunization (NTAGI) recommends this recommendation.

Published

2024-05-13

Issue

Section

Articles